Anew Medical, Inc.
A biopharmaceutical company focused on identifying, developing and commercializing amyotrophic lateral sclerosis (ALS) and other novel gene therapy treatments and in vitro diagnostics for neurodegenerative diseases, including Alzheimer's disease, cancer and other age-related conditions. The company develops and licenses its proprietary product platform as well as generic and biosimilar biologics. Based in Delaware.
Overview
Overview | |
|---|---|
Country | NY |
State | |
Employees | 1 |
Founded | 2019 |
Financials | |
|---|---|
Market Capitalization | 24.51M |
Revenue | |
Operating Income | -0.98M |
Operating Margin | |
Net Income | -2.50M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3019 / 5373 |
Sector : Healthcare | 218 / 1144 |
Industry : Biotechnology | 38 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4873 / 5565 |
Sector : Healthcare | 924 / 1182 |
Industry : Biotechnology | 513 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3054 / 5436 |
Sector : Healthcare | 219 / 1164 |
Industry : Biotechnology | 47 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 5311 / 5330 |
Sector : Healthcare | 1169 / 1174 |
Industry : Biotechnology | 663 / 667 |